Matthew Wilson is a senior partner in McKinsey’s New York office, where he has spent the last 15 years. He works across healthcare, serving clients across the public, private, and social sectors. His clients include a mix of biotechs and pharma, governments, foundations, private equity firms, academic medical centers, public private partnerships, and healthcare services companies. He is passionate about using R&D and innovation to transform healthcare and improve patient outcomes around the world.
Matt leads McKinsey’s work in public health and has served more than 15 governments across the world, covering a wide range of topics including infectious disease management, immunization, health system management, and innovation. He is currently helping to lead McKinsey’s global client response to COVID-19, coordinating a global team of experts in public health, crisis response, supply chain, and economics to support the public health response and help organizations manage their own response.
Matt serves on the board of Brooklyn Museum and is a member of the Council on Foreign Relations.
Published work
“Advancing Global Health Equity in Oncology,” Cancer Discovery, September 2024
“Health-related climate adaptation: How to innovate and scale global action for local needs,” McKinsey Health Institute, August 2024
“Public health’s inflection point with generative AI,” McKinsey & Company, February 2024
“Future-proofing health systems for climate risks and pandemics,” McKinsey & Company, December 2023
“How digital tools could boost efficiency in African health systems,” McKinsey & Company, March 2023
“Measuring preparedness: Are public health systems ready for the next pandemic?,” McKinsey & Company, October 2022
“The gathering storm: The affordability challenge of endemic COVID-19,” McKinsey & Company, September 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, July 2022
“Care for the caretakers: Building the global public health workforce,” McKinsey & Company, July 2022
“Ten lessons from the first two years of COVID-19,” McKinsey & Company, March 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, March 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, December 2021
“Unlocking digital healthcare in lower- and middle-income countries,” McKinsey & Company, November 2021
“Pandemic to endemic: How the world can learn to live with COVID-19,” McKinsey & Company, October 2021
“When will the COVID-19 pandemic end?,” McKinsey & Company, August 2021
“The future of Emergency Operation Centers: Six shifts to consider from COVID-19,” McKinsey & Company, July 2021
“All in the mix: Why US COVID-19 cases rose and fell, and what comes next,” McKinsey & Company, March 2021
“When will the COVID-19 pandemic end?,” McKinsey & Company, March 2021
“Forum Spotlight: Global health in the post-COVID-19 era,” Bloomberg New Economy Forum, Fall 2020
The global response to AMR: momentum, success, and critical gaps, Wellcome, November 2020
“When will the COVID-19 pandemic end?,” McKinsey & Company, September 2020
“COVID-19: Implications for business,” McKinsey & Company, August 2020
“How investing in health has a significant economic payoff for developing economies,” Brookings Institution, July 2020
“Ten innovations that can improve global health,” McKinsey Global Institute, July 2020
“Not the last pandemic: Investing now to reimagine public-health systems,” McKinsey & Company, July 2020
“Prioritizing health: A prescription for prosperity,” McKinsey Global Institute, July 2020
“Return: A new muscle, not just a plan,” McKinsey & Company, May 2020
“Crushing coronavirus uncertainty: The big ‘unlock’ for our economies,” McKinsey & Company, May 2020
“Contact tracing for COVID-19: New considerations for its practical application,” McKinsey & Company, May 2020
“How to restart national economies during the coronavirus crisis,” McKinsey & Company, April 2020
Education
Yale University
BA, economics, mathematics
